Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Company announcement – No. 58 / 2021 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons ...
-
Company announcement – No. 57 / 2021 Zealand Pharma to Participate in Morgan Stanley 19th Annual Global Healthcare Conference Copenhagen, DK and Boston, MA, U.S. September 3, 2021 – Zealand Pharma...
-
Company announcement – No. 56 / 2021 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons ...
-
Company announcement - No. 56 / 2021 New Employee Elected Director to the board of Zealand Pharma A/S Copenhagen, DK and Boston, MA, U.S. September 1, 2021 – Zealand Pharma A/S (“Zealand”) (Nasdaq:...
-
Company announcement – No. 55 / 2021 Zealand Pharma to Participate in Goldman Sachs 11th Annual Biotech Symposium Copenhagen, DK and Boston, MA, U.S. August 31, 2021 – Zealand Pharma A/S...
-
Company announcement – No. 54 / 2021 Total number of shares and voting rights in Zealand Pharma at August 31, 2021 Copenhagen, DK and Boston, MA, August 31, 2021 – Zealand Pharma A/S (“Zealand”)...
-
Company announcement – No. 53 / 2021 Zealand Pharma increases its share capital as a consequence of exercise of employee warrants Copenhagen, DK and Boston, MA, U.S. August 20, 2021 –...
-
Company announcement – No. 52 / 2021 Zealand Pharma Announces First Patient Dosed in EASE-SBS 4 Phase 3b Trial Assessing Glepaglutide in Patients with Short Bowel Syndrome The EASE-SBS 4 Phase 3b...
-
Company announcement No. 51 / 2021 Employee Elected Director to step down from the board of Zealand Pharma A/S Copenhagen, DK, August 13, 2021 – Zealand Pharma A/S (“Zealand”) (Nasdaq: ZEAL)...
-
Company annoucement - No. 50 / 2021 Interim report for H1 2021 Zealand Pharma Launches ZEGALOGUE® (dasiglucagon) Injection and Advances Pipeline Programs Across Multiple Therapeutic Areas ...